PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33030105-0	2022	Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.	naloxegol	51-60	angiotensin converting enzyme 2	Homo sapiens	105-110	
33030105-9	2022	Finally, a long MD analysis revealed two select candidate ligands, including ritonavir and naloxegol, highly stabilizing those key residues engaged in RBD-hACE2 interaction.	naloxegol	91-100	angiotensin converting enzyme 2	Homo sapiens	155-160